Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
Recruiting
Observational Study
Juvenile Idiopathic Arthritis (JIA)
Childhood Rheumatic Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 7 – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Hacettepe University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Juvenile idiopathic arthritis (JIA) is the primary rheumatic disease reported to affect the pediatric population. Research suggests that parents' thoughts and feelings about their child's pain, specifically with JIA diagnosis, may influence treatment compliance. Considering that this situation may also affect children's adherence to treatment, the identification and management of parents' catastro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Between 7-18 years of age
* Diagnosed with JIA
* Individuals who volunteer to participate in the study will be included.
Exclusion Criteria:
* Having advanced heart/lung/liver/kidney disease, neurological disease, or malignancies
* Having undergone major orthopedic surgery
*…
Contacts